3.5. Relationship between (CD25+/CD8+) (CD25+/CD4+) (CD25+/(CD8+ + CD4+)) and Postoperative Survival Rate of NSCLC Patients. This evidence concerns the gene CD8A and non-small cell lung carcinoma.